{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Heart failure",
      "Left heart disease",
      "Pulmonary hypertension"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33541616",
  "DateCompleted": {
    "Year": "2021",
    "Month": "07",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "07",
    "Day": "14"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.ccm.2020.11.002",
      "S0272-5231(20)30114-3"
    ],
    "Journal": {
      "ISSN": "1557-8216",
      "JournalIssue": {
        "Volume": "42",
        "Issue": "1",
        "PubDate": {
          "Year": "2021",
          "Month": "Mar"
        }
      },
      "Title": "Clinics in chest medicine",
      "ISOAbbreviation": "Clin Chest Med"
    },
    "ArticleTitle": "Pulmonary Hypertension in Left Heart Disease.",
    "Pagination": {
      "StartPage": "39",
      "EndPage": "58",
      "MedlinePgn": "39-58"
    },
    "Abstract": {
      "AbstractText": [
        "Pulmonary hypertension is common in left heart disease and is related most commonly to passive back transmission of elevated left atrial pressures. Some patients, however, may develop pulmonary vascular remodeling superimposed on their left-sided heart disease. This review provides a contemporary appraisal of existing criteria to diagnose a precapillary component to pulmonary hypertension in left heart disease as well as discusses etiologies, management issues, and future directions."
      ],
      "CopyrightInformation": "Copyright \u00a9 2020 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55906, USA."
          }
        ],
        "LastName": "Reddy",
        "ForeName": "Yogesh N V",
        "Initials": "YNV"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55906, USA. Electronic address: borlaug.barry@mayo.edu."
          }
        ],
        "LastName": "Borlaug",
        "ForeName": "Barry A",
        "Initials": "BA"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 HL128526",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 HL126638",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "U01 HL125205",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "U10 HL110262",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Clin Chest Med",
    "NlmUniqueID": "7907612",
    "ISSNLinking": "0272-5231"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "diagnosis",
        "etiology",
        "therapy"
      ],
      "DescriptorName": "Heart Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "Hypertension, Pulmonary"
    }
  ],
  "CoiStatement": "Disclosures None."
}